Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women - Related Studies

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

This study is currently recruiting participants.

Study NCT00004400. Last updated on June 23, 2005. Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections
		Cachexia

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Infection

3	More general conditions related to this trial
		Body Weight
		Body Weight Changes
		Emaciation
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Signs and Symptoms
		Slow Virus Diseases
		Virus Diseases
		Weight Loss

4	Interventions listed in this trial
		testosterone

5	Additional drug interventions recognized in this trial
		Methyltestosterone
		Testosterone 17 beta-cypionate

6	More general drug interventions related to this trial
		Anabolic Agents
		Androgens
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		FDA Office of Orphan Products Development
		Charles Drew University of Medicine and Science